UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Elevated pre-activation basal level of nuclear NF-κB in native macrophages accelerates LPS-induced translocation of cytosolic NF-κB into the cell nucleus

Scientific reports, 2019-03, Vol.9 (1), p.4563-4563, Article 4563

2019

Volltextzugriff (PDF)

Ezrin Peptide Therapy from HIV to COVID: Inhibition of Inflammation and Amplification of Adaptive Anti-Viral Immunity

International journal of molecular sciences, 2021-11, Vol.22 (21), p.11688

2021

Volltextzugriff (PDF)

Anticancer Mechanisms in Two Murine Bone Marrow-Derived Dendritic Cell Subsets Activated with TLR4 Agonists

The Journal of immunology (1950), 2018-04, Vol.200 (8), p.2656-2669

2018

Volltextzugriff (PDF)

Antigen receptor repertoire profiling from RNA-seq data

Nature biotechnology, 2017-10, Vol.35 (10), p.908-911

2017

Volltextzugriff (PDF)

Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer

Cancer cell, 2024-05, Vol.42 (5), p.759-779.e12

2024

Volltextzugriff (PDF)

Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer

Journal of translational medicine, 2014-11, Vol.12 (1), p.322, Article 322

2014

Volltextzugriff (PDF)

Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy

Clinical & experimental metastasis, 2014-02, Vol.31 (2), p.185-198

2014

Volltextzugriff (PDF)

The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization

Vaccine, 2010-02, Vol.28 (8), p.1987-1996

2010

Volltextzugriff (PDF)

Anti-cancer mechanisms in two murine bone marrow derived-DC subsets activated with Toll-like receptor 4 agonists

The Journal of immunology (1950), 2018-03, Vol.200 (8), p.2656-2669

2018

Volltextzugriff (PDF)

Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax registered , as a therapeutic strategy for metastatic breast cancer

Journal of translational medicine, 2014-01, Vol.12 (1), p.322-322

2014

Volltextzugriff (PDF)

The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization

Vaccine, 2010, Vol.28 (8), p.1987-1996

2010

Volltextzugriff (PDF)

Immunopharmacology of some new polymeric immunostimulants

International journal of immunopharmacology, 1991, Vol.13 (6), p.705-705

1991

Volltextzugriff (PDF)

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy

Cancer cell, 2021-06, Vol.39 (6), p.845-865.e7

2021

Volltextzugriff (PDF)

Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts

PloS one, 2018-01, Vol.13 (1), p.e0191574-e0191574

2018

Volltextzugriff (PDF)

Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma

Science translational medicine, 2023-01, Vol.15 (680), p.eabn6758

2023

Volltextzugriff (PDF)

Abstract 4418: Integrated whole exome and transcriptome analyses of the tumor and microenvironment provide new opportunities for rational design of cancer therapy

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4418-4418

2020

Volltextzugriff (PDF)

The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector

BMC immunology, 2018-07, Vol.19 (1), p.26-26, Article 26

2018

Volltextzugriff (PDF)

Abstract 507: Association of circulating myeloid derived suppressor cells with systemic lymphopenia following chemoradiotherapy in glioblastoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.507-507

2021

Volltextzugriff (PDF)

Abstract 161: Evaluating the clinical utility of RNA-seq-based PD-L1 expression and cellular deconvolution as alternatives to conventional immunohistochemistry in clear cell renal cell carcinoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.161-161

2021

Volltextzugriff (PDF)

Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer

Clinical cancer research, 2021-06, Vol.27 (12), p.3478-3490

2021

Volltextzugriff (PDF)

Synthetic peptide TEKKRRETVEREKE derived from ezrin induces differentiation of NIH/3T3 fibroblasts

European journal of pharmacology, 2017-09, Vol.811, p.249-259

2017

Volltextzugriff (PDF)

Multi-omics analysis of mantle cell lymphoma reveals an immune-cold tumor microenvironment associated with ibrutinib resistance

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.8055-8055

2020

Volltextzugriff (PDF)

Correlation of PI3K upregulation with NOTCH2 mutations in ibrutinib-resistant mantle cell lymphoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e20065-e20065

2020

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(44)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Elevated pre-activation basal level of nuclear NF-κB in native macrophages accelerates LPS-induced translocation of cytosolic NF-κB into the cell nucleus

Ezrin Peptide Therapy from HIV to COVID: Inhibition of Inflammation and Amplification of Adaptive Anti-Viral Immunity

Anticancer Mechanisms in Two Murine Bone Marrow-Derived Dendritic Cell Subsets Activated with TLR4 Agonists

Antigen receptor repertoire profiling from RNA-seq data

Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer

Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer

Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy

The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization

Anti-cancer mechanisms in two murine bone marrow derived-DC subsets activated with Toll-like receptor 4 agonists

Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax registered , as a therapeutic strategy for metastatic breast cancer

The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization

Immunopharmacology of some new polymeric immunostimulants

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy

Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts

Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma

Abstract 4418: Integrated whole exome and transcriptome analyses of the tumor and microenvironment provide new opportunities for rational design of cancer therapy

Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes

The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector

Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations

Abstract 507: Association of circulating myeloid derived suppressor cells with systemic lymphopenia following chemoradiotherapy in glioblastoma

Abstract 161: Evaluating the clinical utility of RNA-seq-based PD-L1 expression and cellular deconvolution as alternatives to conventional immunohistochemistry in clear cell renal cell carcinoma

Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer

Synthetic peptide TEKKRRETVEREKE derived from ezrin induces differentiation of NIH/3T3 fibroblasts

Multi-omics analysis of mantle cell lymphoma reveals an immune-cold tumor microenvironment associated with ibrutinib resistance

Correlation of PI3K upregulation with NOTCH2 mutations in ibrutinib-resistant mantle cell lymphoma

Suchergebnisse filtern